Norway: Nordic Nanovector appoints Skullerud as new CEO

Nordic Nanovector, a biopharmaceutical company developing therapeutics that target haematological cancers, has appointed Erik Skullerud as CEO. He will be based in the company’s office in Zug but will split his time between Switzerland and head office in Oslo, Norway. He replaces Malene Brondberg who had stepped up to the position of interim CEO in…

You must be a HMI Subscriber to view this content.

Subscribe Now »